您好,欢迎来到阿仪网! 请登录 免费注册

  • 高级会员服务
  • |
  • 广告位服务
  • |
  • 设为首页
  • |
  • 收藏本站
  • |
  • 诚信档案

    • 会员类型:旗舰版会员
    • 阿仪网旗舰版会员:9年
    • 工商认证【已认证】
    • 最后认证时间:
    • 注册号: 【已认证】
    • 法人代表: 【已认证】
    • 企业类型:经销商 【已认证】
    • 注册资金:人民币50万 【已认证】
    • 产品数:

上海雅吉生物科技有限公司 主营产品:ELISA试剂盒,免疫组化试剂盒,PCR检测盒,金标试纸,发光试剂盒,抗体,血清,细胞等

第9年

当前位置: 阿仪网 > 上海雅吉生物科技有限公司 > 产品展示 > 抗体 > 一抗 > 肿瘤细胞调亡素/死亡受体5抗体Ys-1696R

肿瘤细胞调亡素/死亡受体5抗体Ys-1696R

价格:¥电议

品牌名称:$brandModel.Title型号:Ys-1696R 原产地:中国大陆 更新时间:2026/11/10 8:31:36

产品摘要:肿瘤细胞调亡素/死亡受体5抗体具有高纯度、高效价、高特异性的特点,本公司提供针对人源,大鼠,小鼠等种属蛋白的多种单抗及多抗产品,可以应用于多种实验。25,000多种抗体 靶向覆盖多个通路的关键人源蛋白

支付方式:

  • 支付宝 微信 银行转账

产品完善度: 访问次数:574

企业档案

会员类型:旗舰版

已获得阿仪网信誉   等级评定
90成长值

(0 -40)基础信誉积累,可浏览访问

(41-90)良好信誉积累,可接洽商谈

(91+  )优质信誉积累,可持续信赖

阿仪网旗舰版会员:9年

工商认证 【已认证】

最后认证时间:

注册号: 【已认证】

法人代表: 【已认证】

参观次数:7948944

手机网站:http://wap.app17.com/c137908/

旗舰版网址:http://www.yajiml.com

详细内容

产品编号Ys-1696R

英文名称DR5

中文名称肿瘤细胞调亡素/死亡受体5抗体

别 名Tumor necrosis factor receptor superfamily member 10B; TNFRSF10B; sTRAIL Receptor 2; Death receptor 5; CD 262; CD262; CD262 antigen; Death domain containing receptor for TRAIL/Apo2L; Death receptor 5; DR 5; Fas like protein precursor; KILLER; KILLER/DR5; p53 regulated DNA damage inducible cell death receptor (killer); TNF related apoptosis inducing ligand receptor 2; TNF-related apoptosis-inducing ligand receptor 2; TRAIL R2; TRAIL receptor 2; TRAILR2; TRANCER; TRICK2; TRICK2A; TRICK2B; TRICKB; Tumor necrosis factor receptor like protein ZTNFR9; ZTNFR9; TR10B_HUMAN.


抗体来源Rabbit

克隆类型Polyclonal

交叉反应Human, (predicted: Mouse, Rat, )

产品应用WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100 IF=1:100-500 (石蜡切片需做抗原修复)

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

理论分子量48kDa

细胞定位细胞膜

性 状Liquid

浓 度1mg/ml

免 疫 原KLH conjugated synthetic peptide derived from rat DR5: 301-381/381

亚 型IgG

纯化方法affinity purified by Protein A

缓 冲 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

保存条件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.

注意事项This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

PubMedPubMed

产品介绍The protein encoded by this gene is a member of the TNF-receptor superfamily, and contains an intracellular death domain. This receptor can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL/APO-2L), and transduces an apoptosis signal. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. Two transcript variants encoding different isoforms and one non-coding transcript have been found for this gene. [provided by RefSeq, Mar 2009]


Function:

Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappa-B. Essential for ER stress-induced apoptosis.


Subcellular Location:

Cell Membrane


Tissue Specificity:

Widely expressed in adult and fetal tissues; very highly expressed in tumor cell lines such as HeLaS3, K-562, HL-60, SW480, A-549 and G-361; highly expressed in heart, peripheral blood lymphocytes, liver, pancreas, spleen, thymus, prostate, ovary, uterus, placenta, testis, esophagus, stomach and throughout the intestinal tract; not detectable in brain.


DISEASE:

Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. Note=The disease may be caused by mutations affecting the gene represented in this entry.


Similarity:

Contains 1 death domain.

Contains 3 TNFR-Cys repeats.


热门标签:肿瘤细胞调亡素/死亡受体5抗体,抗体

相关文章

相关产品

快速导航

在线咨询5分钟应答

提交